Wealthgarden F.S. LLC Journey Medical Corp Transaction History
Wealthgarden F.S. LLC
- $1.64 Trillion
- Q3 2024
A detailed history of Wealthgarden F.S. LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Wealthgarden F.S. LLC holds 10,430 shares of DERM stock, worth $57,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,430Holding current value
$57,260% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
40Shares Held
2.93MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.75 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.79 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.73 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.47 Million0.0% of portfolio
-
American Financial Group Inc180KShares$988,2000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $63.7M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...